Literature DB >> 10073703

Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively.

B Borrego, M M Lorenzo, R Blasco.   

Abstract

Vaccinia virus produces two different infectious forms, intracellular mature virus (IMV) and extracellular enveloped virus (EEV). Acquisition of the EEV envelope occurs by wrapping of IMV with vesicles of the trans-Golgi network (TGN). The most abundant protein in the envelope of EEV, P37, is a 37 kDa palmitylated protein encoded by the F13L gene. P37 is located in the inner side of the EEV envelope and accumulates in the TGN during infection. Deletion of gene F13L results in a severe defect in the wrapping process, although normal levels of IMV are produced. A cell line, derived from RK-13 cells, was obtained that stably expressed P37 (RK(P37)), and the properties of the protein were studied in the absence of other viral polypeptides. P37 produced in RK(P37) cells differed from P37 produced in vaccinia-infected cells in terms of hydrophobicity and intracellular distribution. Despite these differences, RK(P37) cells partially complemented the phenotypic defect of vaccinia virus P37- mutants. EEV production and cell-to-cell virus spread by mutant viruses were increased significantly in RK(P37) cells when compared to normal RK-13 cell cultures. Infection of RK(P37) cells with P37- virus substantially altered the hydrophobicity and the intracellular distribution of P37 in those cells. These results indicate the requirement of the infection context for determination of the normal palmitylation and intracellular localization of P37.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073703     DOI: 10.1099/0022-1317-80-2-425

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus.

Authors:  Matloob Husain; Bernard Moss
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.

Authors:  Beatriz Perdiguero; Rafael Blasco
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles.

Authors:  M Husain; B Moss
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.

Authors:  M M Lorenzo; I Galindo; G Griffiths; R Blasco
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

6.  Characterisation of an Anti-Vaccinia Virus F13 Single Chain Fragment Variable from a Human Anti-Vaccinia Virus-Specific Recombinant Immunoglobulin Library.

Authors:  Henrike P Ahsendorf; Ulrike S Diesterbeck; Sven-Kevin Hotop; Michael Winkler; Mark Brönstrup; Claus-Peter Czerny
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

7.  Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice.

Authors:  Douglas W Grosenbach; Aklile Berhanu; David S King; Stacie Mosier; Kevin F Jones; Robert A Jordan; Tove' C Bolken; Dennis E Hruby
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.